FY2025 Earnings
Financial report interval: 2024.12.31 - 2025.12.31
Overview: Biodexa Pharmaceuticals(BDRX) the Revenue is 0 (--%);the EBIT is -11.64 M (-0.85%);the EPS is -0.0007 (--%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B--
----
----
EBIT
-0.01B0.85%
----
----
EPS
-0.0007--
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf